Gallium Maltolate

N/A

Report date: 2026/04/24 20:01:59
NME

Base Information

Drug NameGallium Maltolate
Drug Alias Name麦芽酚镓麦芽糖镓
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionRibonucleotide reductase inhibitors
TargetsRibonucleotide reductase
Therapy Area/IndicationsUrinary Bladder NeoplasmsProstatic NeoplasmsMultiple Myeloma +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTitan Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesThe Medical College Of Wisconsin Nonprofit
Inactive CompaniesTitan Pharmaceuticals Inc
Active IndicationsGlioblastoma
Inactive IndicationsUrinary Bladder NeoplasmsProstatic NeoplasmsMultiple Myeloma +[4] 

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank